Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  yttrium Y 90 glass microspheres
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-18 of 18 for your search:
Start Over
Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: PCI-04128, CDR0000425333, PCI-IRB-0501021, NCT00109954
Comparing Hepatic Intra-arterial Injection of Yttrium-90 Microspheres Versus Fluorouracil (5FU) in Colorectal Cancer Metastatic to the Liver Only
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: Sir-Spheres1, NCT00199173
Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CTCT 06-11, NCT00493883
Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: NMRC - AHCC05, NCT00712790
TheraSphere for the Treatment of Liver Metastases
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: G040148, NCT00511862
Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 06057, P30CA033572, CHNMC-06057, CDR0000579146, NCI-2010-00429, NCT00589030
Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: INT 30/90, NCT00910572
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: J09150, NA_00035790, J09150, NCT01177007
Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MCC-16236, NCT01253148
Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MCC-16764, NCT01581307
Sorafenib and Yttrium-90 Glass Microspheres for Advanced Hepatocellular Carcinoma (HCC)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2012-0870, NCI-2013-01667, NCT01900002
Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: NU 08I5, STU00007062, NCI-2009-01122, NCT00858429
Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer
Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NU 07Q1, P30CA060553, NU-IRB-STU00002799, NCT00739167
TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)
Phase: No phase specified
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: TheraSphere - 421.03, NCT00683631
FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer
Phase: No phase specified
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: STX0206, NCT00724503
TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis
Phase: No phase specified
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: IRB00015167, NCT01556282
Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CASE1612, NCI-2012-02203, NCT01730157
Start Over